atropine: be used for bradycardia

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents drug
Weight: 0.66
, alkaloid
Weight: 0.59
, agent
Weight: 0.57
, substance
Weight: 0.55
, medicine
Weight: 0.51
Siblings phenobarbital
Weight: 0.36
, acetaminophen
Weight: 0.36
, ibuprofen
Weight: 0.35
, morphine
Weight: 0.35
, metronidazole
Weight: 0.35

Related properties

Property Similarity
be used for bradycardia 1.00
be given for bradycardia 0.98
be contraindicated in prostatic hypertrophy 0.80
be contraindicated in hypertrophy 0.80
be contraindicated in myasthenia gravis 0.78
be contraindicated in heart transplant patients 0.77
be contraindicated in hypothermia 0.77
be contraindicated in heart block 0.77
is administered preoperatively 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.40
¬ Salient(atropine, be used for bradycardia)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.98
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.24
¬ Remarkable(atropine, be given for bradycardia)
0.68
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.98
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.31
¬ Salient(atropine, be given for bradycardia)
0.64
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.98
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.43
¬ Plausible(atropine, be given for bradycardia)
0.61
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.98
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.65
¬ Typical(atropine, be given for bradycardia)
0.52
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.80
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.59
¬ Typical(atropine, be contraindicated in prostatic hypertrophy)
0.51
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.76
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.52
¬ Typical(atropine, is administered preoperatively)
0.49
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.76
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.45
¬ Plausible(atropine, is administered preoperatively)
0.49
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.76
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.42
¬ Salient(atropine, is administered preoperatively)
0.48
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.77
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.43
¬ Remarkable(atropine, be contraindicated in hypothermia)
0.48
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.80
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.72
¬ Typical(atropine, be contraindicated in hypertrophy)
0.47
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.78
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.49
¬ Remarkable(atropine, be contraindicated in myasthenia gravis)
0.47
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.76
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.45
¬ Remarkable(atropine, is administered preoperatively)
0.47
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.77
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.47
¬ Remarkable(atropine, be contraindicated in heart transplant patients)
0.46
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.80
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.63
¬ Plausible(atropine, be contraindicated in prostatic hypertrophy)
0.44
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.77
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.54
¬ Remarkable(atropine, be contraindicated in heart block)
0.43
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.77
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.85
¬ Typical(atropine, be contraindicated in hypothermia)
0.42
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.80
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.72
¬ Plausible(atropine, be contraindicated in hypertrophy)
0.42
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.78
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.91
¬ Typical(atropine, be contraindicated in myasthenia gravis)
0.41
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.77
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.92
¬ Typical(atropine, be contraindicated in heart block)
0.40
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.77
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.74
¬ Plausible(atropine, be contraindicated in hypothermia)
0.40
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.77
Evidence: 0.59
Typical(atropine, be used for bradycardia)
Evidence: 0.97
¬ Typical(atropine, be contraindicated in heart transplant patients)
0.38
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.80
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.72
¬ Remarkable(atropine, be contraindicated in hypertrophy)
0.37
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.78
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.83
¬ Plausible(atropine, be contraindicated in myasthenia gravis)
0.37
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.77
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.74
¬ Salient(atropine, be contraindicated in hypothermia)
0.36
Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.80
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.79
¬ Salient(atropine, be contraindicated in prostatic hypertrophy)
0.36
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.77
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.86
¬ Plausible(atropine, be contraindicated in heart block)
0.35
Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.80
Evidence: 0.38
Remarkable(atropine, be used for bradycardia)
Evidence: 0.78
¬ Remarkable(atropine, be contraindicated in prostatic hypertrophy)
0.34
Rule weight: 0.85
Evidence weight: 0.50
Similarity weight: 0.80
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.83
¬ Salient(atropine, be contraindicated in hypertrophy)
0.34
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.77
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.91
¬ Plausible(atropine, be contraindicated in heart transplant patients)
0.33
Rule weight: 0.85
Evidence weight: 0.49
Similarity weight: 0.78
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.85
¬ Salient(atropine, be contraindicated in myasthenia gravis)
0.31
Rule weight: 0.85
Evidence weight: 0.47
Similarity weight: 0.77
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.90
¬ Salient(atropine, be contraindicated in heart block)
0.29
Rule weight: 0.85
Evidence weight: 0.44
Similarity weight: 0.77
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.94
¬ Salient(atropine, be contraindicated in heart transplant patients)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.40
Salient(atropine, be used for bradycardia)
Evidence: 0.59
¬ Typical(atropine, be used for bradycardia)
Evidence: 0.38
¬ Remarkable(atropine, be used for bradycardia)

Typical implies Plausible

0.33
Rule weight: 0.48
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.47
Plausible(atropine, be used for bradycardia)
Evidence: 0.59
¬ Typical(atropine, be used for bradycardia)